Kewei Rong

572 total citations · 1 hit paper
24 papers, 399 citations indexed

About

Kewei Rong is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kewei Rong has authored 24 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Kewei Rong's work include Bone Metabolism and Diseases (9 papers), Spine and Intervertebral Disc Pathology (7 papers) and Bone health and treatments (5 papers). Kewei Rong is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Spine and Intervertebral Disc Pathology (7 papers) and Bone health and treatments (5 papers). Kewei Rong collaborates with scholars based in China, Australia and Germany. Kewei Rong's co-authors include Xiao Yang, Jie Zhao, Tangjun Zhou, Pu Zhang, Jingke Fu, Jiaxin Li, Xiankun Cao, An Qin, Keyu Kong and Peixiang Ma and has published in prestigious journals such as Nature Communications, Biochemical Pharmacology and Advanced Science.

In The Last Decade

Kewei Rong

24 papers receiving 396 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression

2023 122 citations Xiao Yang, Jiaxin Li et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kewei Rong China	11	204	90	62	60	59	24	399
Chenyu Wu China	13	250 1.2×	110 1.2×	55 0.9×	39 0.7×	41 0.7×	32	473
Nianhu Li China	10	248 1.2×	85 0.9×	67 1.1×	61 1.0×	24 0.4×	34	417
Katarzyna Ratajczak‐Wielgomas Poland	15	219 1.1×	40 0.4×	33 0.5×	44 0.7×	53 0.9×	42	580
Yonglong Jin China	14	209 1.0×	132 1.5×	97 1.6×	60 1.0×	44 0.7×	29	473
Jie Jin China	13	182 0.9×	46 0.5×	59 1.0×	94 1.6×	21 0.4×	31	385
Dianming Jiang China	11	208 1.0×	38 0.4×	38 0.6×	52 0.9×	23 0.4×	16	348
Huihao Zhang China	12	131 0.6×	94 1.0×	57 0.9×	23 0.4×	20 0.3×	25	410
Weijian Chen China	10	205 1.0×	74 0.8×	48 0.8×	42 0.7×	13 0.2×	29	341
Tomoyo Kawakubo‐Yasukochi Japan	14	303 1.5×	52 0.6×	25 0.4×	32 0.5×	21 0.4×	29	588
Bingbing Yu China	11	165 0.8×	128 1.4×	55 0.9×	21 0.3×	60 1.0×	14	332

Countries citing papers authored by Kewei Rong

Since Specialization

Citations

This map shows the geographic impact of Kewei Rong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Rong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Rong more than expected).

Fields of papers citing papers by Kewei Rong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Rong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Rong. The network helps show where Kewei Rong may publish in the future.

Co-authorship network of co-authors of Kewei Rong

This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Rong. A scholar is included among the top collaborators of Kewei Rong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Rong. Kewei Rong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rong, Kewei, Dezheng Wang, Cheng Zhang, et al.. (2025). Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis. Bone Research. 13(1). 60–60. 4 indexed citations

Cao, Xiankun, Kewei Rong, Pu Zhang, et al.. (2025). A novel application perspective of the clinical-used drug verapamil on osteoporosis via targeting Txnip. Journal of Orthopaedic Translation. 50. 158–173. 1 indexed citations

Cao, Xiankun, Kexin Liu, Jinbo Yuan, et al.. (2025). Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis. Journal of Advanced Research. 77. 221–234. 2 indexed citations

Yang, Xiao, Kewei Rong, Yangzi Yang, et al.. (2025). Engineered Spirulina platensis for treating rheumatoid arthritis and restoring bone homeostasis. Nature Communications. 16(1). 4434–4434. 3 indexed citations

Kong, Keyu, Pengcheng Liu, Xuzhuo Chen, et al.. (2025). Regulating obesity-induced osteoarthritis by targeting p53-FOXO3, osteoclast ferroptosis, and mesenchymal stem cell adipogenesis. Nature Communications. 16(1). 4532–4532. 6 indexed citations

Zhao, Chen, Kewei Rong, Pengcheng Liu, et al.. (2024). Preventing periprosthetic osteolysis in aging populations through lymphatic activation and stem cell-associated secretory phenotype inhibition. Communications Biology. 7(1). 962–962. 1 indexed citations

Liu, Kexin, Kewei Rong, Xiao Yang, et al.. (2024). Homoplantaginin alleviates intervertebral disc degeneration by blocking the NF-κB/MAPK pathways via binding to TAK1. Biochemical Pharmacology. 226. 116389–116389. 5 indexed citations

Yang, Xiao, Jiaxin Li, Pu Zhang, et al.. (2023). Polydopamine Nanoparticles Targeting Ferroptosis Mitigate Intervertebral Disc Degeneration Via Reactive Oxygen Species Depletion, Iron Ions Chelation, and GPX4 Ubiquitination Suppression. Advanced Science. 10(13). e2207216–e2207216. 122 indexed citations breakdown →

Rong, Kewei, Deqiang Yao, Xiankun Cao, et al.. (2023). The structural pathology for hypophosphatasia caused by malfunctional tissue non-specific alkaline phosphatase. Nature Communications. 14(1). 4048–4048. 27 indexed citations

10.

Zhang, Pu, Kewei Rong, Lei Cui, et al.. (2023). Cynarin alleviates intervertebral disc degeneration via protecting nucleus pulposus cells from ferroptosis. Biomedicine & Pharmacotherapy. 165. 115252–115252. 26 indexed citations

11.

Wang, Xin, Tangjun Zhou, Xiao Yang, et al.. (2023). DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1‐Mediated NRF2 Ubiquitination. Advanced Science. 10(14). e2204438–e2204438. 40 indexed citations

12.

Kong, Keyu, Minghao Jin, Chen Zhao, et al.. (2023). Mechanical overloading leads to chondrocyte degeneration and senescence via Zmpste24-mediated nuclear membrane instability. iScience. 26(11). 108119–108119. 5 indexed citations

13.

Wang, Zhengting, Lihuan Wang, Yijie Li, et al.. (2022). Scutellarin ameliorates osteoarthritis by protecting chondrocytes and subchondral bone microstructure by inactivating NF-κB/MAPK signal transduction. Biomedicine & Pharmacotherapy. 155. 113781–113781. 16 indexed citations

14.

Cao, Xiankun, Xin Wang, Kewei Rong, et al.. (2022). Specific PFKFB3 Inhibitor Memorably Ameliorates Intervertebral Disc Degeneration via Inhibiting NF‐κB and MAPK Signaling Pathway and Reprogramming of Energy Metabolism of Nucleus Pulposus Cells. Oxidative Medicine and Cellular Longevity. 2022(1). 7548145–7548145. 10 indexed citations

15.

Yang, Xiao, Pu Zhang, Kewei Rong, et al.. (2022). Engeletin Alleviates the Inflammation and Apoptosis in Intervertebral Disc Degeneration via Inhibiting the NF-κB and MAPK Pathways. Journal of Inflammation Research. Volume 15. 5767–5783. 18 indexed citations

16.

Kong, Keyu, Yongyun Chang, Xuzhuo Chen, et al.. (2022). Paxlovid accelerates cartilage degeneration and senescence through activating endoplasmic reticulum stress and interfering redox homeostasis. Journal of Translational Medicine. 20(1). 549–549. 16 indexed citations

17.

Yang, Xiao, Kewei Rong, Zhengting Wang, et al.. (2022). Eupatilin attenuates the senescence of nucleus pulposus cells and mitigates intervertebral disc degeneration via inhibition of the MAPK/NF-κB signaling pathway. Frontiers in Pharmacology. 13. 940475–940475. 18 indexed citations

18.

He, Wenxin, Xiankun Cao, Kewei Rong, et al.. (2021). Combination of AZD3463 and DZNep Prevents Bone Metastasis of Breast Cancer by Suppressing Akt Signaling. Frontiers in Pharmacology. 12. 652071–652071. 3 indexed citations

19.

Luo, Ping, Yong Chen, Kewei Rong, et al.. (2021). ZmSNAC13, a maize NAC transcription factor conferring enhanced resistance to multiple abiotic stresses in transgenic Arabidopsis. Plant Physiology and Biochemistry. 170. 160–170. 25 indexed citations

20.

Cao, Xiankun, Wenxin He, Kewei Rong, et al.. (2021). DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis. Stem Cell Research & Therapy. 12(1). 605–605. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact